Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features
- PMID: 33076874
- PMCID: PMC7570420
- DOI: 10.1186/s12879-020-05504-7
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features
Abstract
Background: Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a novel etiologic agent of viral pneumonia. We aimed to compare clinical features of 165 Italian patients with laboratory confirmed or unconfirmed 2019-nCoV pneumonia.
Methods: On March 31, 2020, hospitalized patients who presented with fever and/or respiratory symptoms, exposures, and presence of lung imaging features consistent with 2019-nCoV pneumonia were included. Before admission to a hospital ward, patients underwent RT-PCR based SARS-CoV-2 RNA detection in their nasopharyngeal swab samples.
Results: Of 165 patients studied, 119 had positive RT-PCR results and 46 were RT-PCR negative for 2 days or longer (i.e., when the last swab sample was obtained). The median age was 70 years (IQR, 58-78), and 123 (74.6%) of 165 patients had at least one comorbidity. The majority of patients (101/165, 61.2%) had a mild pneumonia, and the remaining patients (64/165, 38.8%) a severe/critical pneumonia. We did not find any substantial difference in symptoms, incubation periods, and radiographic/CT abnormalities as well as in many of the biological abnormalities recorded. However, at multivariable analysis, higher concentrations of hemoglobin (OR, 1.34; 95% CI, 1.11-1.65; P = 0.003) and lower counts of leukocytes (OR, 0.81; 95% CI, 0.72-0.90; P < 0.001) were statistically associated with confirmed COVID-19 diagnosis. While mortality rates were similar, patients with confirmed diagnosis were more likely to receive antivirals (95% vs 19.6%, P < 0.001) and to develop ARDS (63% vs 37%, P = 0.003) than those with unconfirmed COVID-19 diagnosis.
Conclusions: Our findings suggest that unconfirmed 2019-nCoV pneumonia cases may be actually COVID-19 cases and that clinicians should be cautious when managing patients with presentations compatible with COVID-19.
Keywords: COVID-19; Clinical and laboratory findings; Outcomes; Pneumonia.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.BMC Infect Dis. 2020 Jul 16;20(1):517. doi: 10.1186/s12879-020-05245-7. BMC Infect Dis. 2020. PMID: 32677909 Free PMC article.
-
Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients.Indian J Ophthalmol. 2020 Jun;68(6):1015-1017. doi: 10.4103/ijo.IJO_1287_20. Indian J Ophthalmol. 2020. PMID: 32461418 Free PMC article.
-
A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients.J Clin Microbiol. 2020 Oct 21;58(11):e01946-20. doi: 10.1128/JCM.01946-20. Print 2020 Oct 21. J Clin Microbiol. 2020. PMID: 32883744 Free PMC article.
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. PMID: 32997361 Updated.
-
Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis.Rev Med Virol. 2020 Jul;30(4):e2112. doi: 10.1002/rmv.2112. Epub 2020 Jun 5. Rev Med Virol. 2020. PMID: 32502331 Free PMC article.
Cited by
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Spatio-temporal characteristics of the novel coronavirus attention network and its influencing factors in China.PLoS One. 2021 Sep 16;16(9):e0257291. doi: 10.1371/journal.pone.0257291. eCollection 2021. PLoS One. 2021. PMID: 34529727 Free PMC article.
-
Comparison of clinical, laboratory and radiological features in confirmed and unconfirmed COVID-19 patients.Future Microbiol. 2021 Dec;16:1389-1400. doi: 10.2217/fmb-2021-0162. Epub 2021 Nov 23. Future Microbiol. 2021. PMID: 34812057 Free PMC article.
-
An IoT Framework for Screening of COVID-19 Using Real-Time Data from Wearable Sensors.Int J Environ Res Public Health. 2021 Apr 12;18(8):4022. doi: 10.3390/ijerph18084022. Int J Environ Res Public Health. 2021. PMID: 33921223 Free PMC article.
-
Diagnosis of COVID-19 in Patients with Negative Nasopharyngeal Swabs: Reliability of Radiological and Clinical Diagnosis and Accuracy Versus Serology.Diagnostics (Basel). 2021 Feb 25;11(3):386. doi: 10.3390/diagnostics11030386. Diagnostics (Basel). 2021. PMID: 33668734 Free PMC article.
References
-
- Lai CC, Wang CY, Wang YH, Hsueh SC, Ko WC, Hsueh PR. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020;55:105946. doi: 10.1016/j.ijantimicag.2020.105946. - DOI - PMC - PubMed
-
- WHO. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. In: Interim guidance. Geneva: World Health Organization; 2020. Available at: https://apps.who.int/iris/bitstream/handle/10665/331501/WHO-COVID-19-lab.... Accessed 26 Apr 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous